Previous Article | Next Article ![]()
Journal of Virology, May 1999, p. 4208-4219, Vol. 73, No. 5
Department of Molecular Biology and
Microbiology1 and Institute of
Pathology,4 School of Medicine, Case Western
Reserve University, Cleveland, Ohio 44106; Avian Disease and
Oncology Laboratory, U.S. Department of Agriculture, Agricultural
Research Station, East Lansing, Michigan 488232;
Department of Pathology, Baylor College of Medicine,
Houston, Texas 770303; and
University of California Davis Cancer Center, Sacramento,
California 958175
Received 29 May 1998/Accepted 12 January 1999
Marek's disease virus, an avian alphaherpesvirus, has been used as
an excellent model to study herpesvirus oncogenesis. One of its
potential oncogenes, MEQ, has been demonstrated to transform a rodent
fibroblast cell line, Rat-2, in vitro by inducing morphological transformation and anchorage- and serum-independent growth and by
protecting cells from apoptosis induced by tumor necrosis factor alpha,
C2-ceramide, UV irradiation, or serum deprivation. In this report, we
show that there is a cell cycle-dependent colocalization of MEQ protein
and cyclin-dependent kinase 2 (CDK2) in coiled bodies and the nucleolar
periphery during the G1/S boundary and early S phase. To
our knowledge, this is the first demonstration that CDK2 is found to
localize to coiled bodies. Such an in vivo association and possibly
subsequent phosphorylation may result in the cytoplasmic translocation
of MEQ protein. Indeed, MEQ is expressed in both the nucleus and the
cytoplasm during the G1/S boundary and early S phase. In
addition, we were able to show in vitro phosphorylation of MEQ by CDKs.
We have mapped the CDK phosphorylation site of MEQ to be serine 42, a
residue in the proximity of the bZIP domain. An
indirect-immunofluorescence study of the MEQ S42D mutant, in which the
CDK phosphorylation site was mutated to a charged residue, reveals more
prominent cytoplasmic localization. This lends further support to the
notion that the translocation of MEQ is regulated by phosphorylation.
Furthermore, phosphorylation of MEQ by CDKs drastically reduces the DNA
binding activity of MEQ, which may in part account for the lack of
retention of MEQ oncoprotein in the nucleus. Interestingly, the
localization of CDK2 in coiled bodies and the nucleolar periphery is
observed only in MEQ-transformed Rat-2 cells, implicating MEQ in
modifying the subcellular localization of CDK2. Taken together, our
data suggest that there is a novel reciprocal modulation between the herpesvirus oncoprotein MEQ and CDK2.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Functional Interactions between Herpesvirus
Oncoprotein MEQ and Cell Cycle Regulator CDK2
*
Corresponding author. Mailing address: UC Davis Cancer
Center, Research Bldg., Rm. 2400B, 4501 X St., Sacramento, CA 95817. Phone: (916) 734-1538. Fax: (916) 734-2589. E-mail:
hkung{at}ucdavis.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|